$HCA News

5 Insightful Analyst Questions From HCA Healthcare’s Q2 Earnings Call

Hospital giant flags $400 million hit from policy change

Goldman Sachs Maintains Buy on HCA Healthcare, Lowers Price Target to $485

Mizuho Maintains Outperform on HCA Healthcare, Lowers Price Target to $475

HCA's Health Insurance Exchange Headwinds, Surgical Softness Led to Guidance Reset, RBC Says

UBS Maintains Buy on HCA Healthcare, Lowers Price Target to $579

Behind HCA's Q2 Beat: One-Time Medicaid Boost and a Growing Insurance Headwind

Morgan Stanley Maintains Underweight on HCA Healthcare, Lowers Price Target to $380

HCA Healthcare Analysts Slash Their Forecasts After Q2 Results

Almost all of HCA’s Affordable Care Act patients are going uninsured. Here’s how that affected Q2

RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

Truist Securities Maintains Buy on HCA Healthcare, Lowers Price Target to $495

Oppenheimer Maintains Outperform on HCA Healthcare, Lowers Price Target to $485

Keybanc Maintains Overweight on HCA Healthcare, Lowers Price Target to $435

Baird Maintains Neutral on HCA Healthcare, Lowers Price Target to $393

Barclays Maintains Equal-Weight on HCA Healthcare, Lowers Price Target to $387

HCA Healthcare (HCA) Faces Third Straight Year Of Mission Health Compliance Concerns

HCA Healthcare, Inc. Q2 2026 Earnings Call Summary

HCA Healthcare Inc (HCA) Q2 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges

HCA Healthcare Q2 Earnings Call Highlights